Pharmaceutical Regulatory Services
Strategic support for drug development, dossiers, quality systems, clinical programs, and global market authorization
Navigate Complex Pharmaceutical Regulations
From development planning and submissions to quality, safety, and lifecycle support
Support designed for pharmaceutical teams managing speed, quality, and submission complexity.
Yuhitech helps pharmaceutical businesses organize strategy, documentation, quality systems, clinical support, and post-approval responsibilities across major regulatory pathways and markets.
Regulatory Affairs
- Global Regulatory Strategy
- Dossier Gap Analysis & Remediation
- CMC Writing & Documentation Review
- ICH Guidelines Compliance
- CTD/ACTD Dossier Preparation
- Computer System Validation (CSV)
- FDA 483 Resolution
- Drug Master File (DMF) Preparation
- ANDA/NDA/IND Submissions
- Clinical Trial Applications (CTA)
- Variation Applications (Type IA, IB, II)
- Marketing Authorization Applications
Quality Assurance & QMS
- GMP & GDP Design Quality
- Equipment Qualification (IQ/OQ/PQ)
- Process Validation
- New Regulations Implementation
- External Audit Preparation
- CAPA Procedure Management
- Investigation & Root Cause Analysis
- ICH Q9: Quality Risk Management
- WHO, FDA, MHRA, TGA Compliance
- Gap Assessment & Remediation
- Cleaning Validation
- Analytical Method Validation
- Stability Studies Design
Regulatory Coverage
Coverage across major regulatory markets and submission pathways
US FDA
IND, NDA, ANDA, DMF submissions
EMA (European Union)
MAA, Variations, CTD dossiers
CDSCO (India)
Drug registration and import licensing support
WHO
Prequalification program support
TGA (Australia)
Australian registration pathways
Health Canada
Drug submissions and regulatory support
SAHPRA (South Africa)
Registration services
MHRA (UK)
UK registration support
Drug Types We Support
Support tailored to a wide range of product categories and development stages
Small Molecules
Biologics
Biosimilars
Generic Drugs
Over-the-Counter (OTC)
Prescription Drugs
Combination Products
Herbal/Ayurvedic (India)
Clinical Development Support
- Protocol Development
- IND/CTA Preparation
- Investigator's Brochure
- Clinical Trial Monitoring
- Clinical Study Reports
- Bioequivalence Studies
- Safety Reporting
- Ethics Committee Submissions
Pharmacovigilance Services
- Safety Database Management
- Adverse Event Reporting
- PSUR/PBRER Preparation
- Risk Management Plans (RMP)
- Signal Detection & Evaluation
- Regulatory Safety Updates
Success Metrics
Approval Success Rate
Average Timeline Reduction
Critical Audit Findings
Accelerate Your Drug Development Journey
Talk with our team about market strategy, dossier readiness, quality, and pharmacovigilance support
Schedule ConsultationPharmaceutical Regulatory FAQs
These FAQs explain how Yuhitech supports pharmaceutical businesses across compliance, submissions, and market planning.
What kind of pharmaceutical companies can work with Yuhitech?
Yuhitech can support pharmaceutical organizations that need regulatory guidance, documentation assistance, compliance support, or help preparing for market entry and lifecycle management activities.
Does the pharmaceutical service cover more than submission support?
Yes. The service is broader than submission preparation alone and can extend to compliance planning, documentation review, regulatory coordination, and support across different project stages.
Which markets are considered in pharmaceutical projects?
The service approach strongly reflects India and EU priorities, while also supporting US and other international market considerations depending on the client product and expansion goals.
Can Yuhitech help with documentation and dossier-related work?
Yes. Documentation support is a core part of the pharmaceutical service offering, especially where businesses need stronger structure, clarity, and regulatory alignment in their materials.
Is Yuhitech useful for companies expanding into new regulated markets?
Yes. The pharmaceutical offering is particularly useful for companies that need practical regulatory support while preparing to enter new markets or strengthen compliance in existing ones.
Can Yuhitech support both development-stage and marketed pharmaceutical products?
Yes. The service can support organizations at different stages, including planning, submissions, compliance strengthening, and ongoing lifecycle-related regulatory needs.
Does the service include quality and GMP-related support?
Yes. Quality and GMP-related support can be part of pharmaceutical engagements where operations and regulatory readiness depend on stronger process control and documentation.
Can Yuhitech help with regulatory remediation or inspection readiness?
Yes. The pharmaceutical service can support remediation, gap closure, documentation strengthening, and broader readiness efforts tied to regulatory expectations.
Is pharmacovigilance-related support part of the service offering?
Yes. Safety and lifecycle support can be included where the business needs structured help beyond core submission work alone.
Can this service support cross-functional pharma teams?
Yes. Pharmaceutical work often touches regulatory, quality, clinical, manufacturing, and documentation stakeholders, so the engagement model is designed to work across functions.
What is the value of using an external pharma regulatory partner?
An external partner can add specialist capacity, stronger documentation discipline, and broader regulatory perspective when internal teams need focused support or added momentum.